BioRem (CVE:BRM) Trading Down 2.7% – Time to Sell?

Shares of BioRem Inc. (CVE:BRM) dropped 2.7% during mid-day trading on Monday . The company traded as low as C$2.85 and last traded at C$2.87. Approximately 45,600 shares were traded during trading, a decline of 11% from the average daily volume of 51,079 shares. The stock had previously closed at C$2.95.

Analyst Ratings Changes

Separately, Cormark raised BioRem to a “moderate buy” rating in a report on Tuesday, December 17th.

BioRem Stock Down 1.4 %

The stock has a market cap of C$42.70 million, a P/E ratio of 12.95 and a beta of 0.85. The company has a current ratio of 1.57, a quick ratio of 1.08 and a debt-to-equity ratio of 48.97. The stock’s 50-day moving average is C$3.04 and its 200-day moving average is C$2.62.

BioRem (CVE:BRM) last released its quarterly earnings results on Wednesday, November 6th. The company reported C$0.12 earnings per share (EPS) for the quarter. BioRem had a net margin of 11.35% and a return on equity of 59.68%.

Insider Buying and Selling

In other news, Director Derek Webb sold 120,000 shares of the company’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of C$2.93, for a total transaction of C$351,600.00. 1.90% of the stock is owned by company insiders.

BioRem Company Profile

BioRem Inc, a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers biofilters for the removal of odors, H2S, VOCs, and HAPs; and biotrickling filters for applications of high levels of H2S or other water-soluble VOCs.